Ayurveda's Panchakarma therapy offers a detoxifying and rejuvenating experience. It restores balance to body and mind. This ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. University of Utah HealthDec 10 2024 The therapy increases the amount of blood the heart ...

Arcellx's anito-cel shows 97% overall response rate and 62% CR/sCR rate in high-risk RRMM patients during Phase 2 iMMagine-1 trial. No severe neurotoxicities observed in over 150 patients dosed ...

These days, therapy has become standardized to some extent. The only thing that hasn’t changed much is the cost. Though cheaper than in-person therapy, online therapy sessions can still be ...

The network meta-analysis yielded the following findings: (1) regarding responder rate, several acupuncture or combined acupuncture and medication approaches, such as electro-acupuncture (EA) + ...

Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient ...

The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona and is evaluating the need for “further regulatory action,” the U.S ...

The FDA last week announced that it is looking into the safety of bluebird bio’s gene therapy Skysona (elivaldogene autotemcel) after new reports of secondary blood cancers in treated patients. The ...

Cupping therapy, which uses cups to create suction on the skin ... This method is also known as full cupping, bleeding cupping, or bloodletting cupping. Wet cupping carries a higher risk of scarring, ...

On Wednesday, the FDA raised concerns about life-threatening hematologic malignancies in patients treated with Bluebird Bio Inc’s (NASDAQ:BLUE) Skysona (elivaldogene autotemcel), a gene therapy ...

a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for its HPC, Cord Blood ...